This resource was last updated in September 2018.

  I. Acute Chemotherapy Treatment Side Effects
  I. Acute Chemotherapy Treatment Side Effects
  A. Anthracyclines
  A. Anthracyclines
  a. Doxorubicin
  a. Doxorubicin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Daunorubicin
  b. Daunorubicin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Idarubicin
  c. Idarubicin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  d. Epirubicin
  d. Epirubicin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  e. Mitoxantrone
  e. Mitoxantrone
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  f. Additional Resources/Other
  f. Additional Resources/Other
  B. VEGF Signaling Pathway Inhibitors
  B. VEGF Signaling Pathway Inhibitors
  a. Bevacizumab
  a. Bevacizumab
  b. Aflibercept
  b. Aflibercept
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Ramucirumab
  c. Ramucirumab
  d. Sunitinib
  d. Sunitinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  e. Sorafenib
  e. Sorafenib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  f. Pazopanib
  f. Pazopanib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  g. Axitinib
  g. Axitinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  h. Vandetanib
  h. Vandetanib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  i. Regorafenib
  i. Regorafenib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  j. Lenvatinib
  j. Lenvatinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  C. Multi-targeted Tyrosine Kinase Inhibitors
  C. Multi-targeted Tyrosine Kinase Inhibitors
  a. Dasatinib
  a. Dasatinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Nilotinib
  b. Nilotinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Ponatinib
  c. Ponatinib
  d. Additional Resources/Other
  d. Additional Resources/Other
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  D. HER 2 Inhibitors
  D. HER 2 Inhibitors
  a. Trastuzumab
  a. Trastuzumab
  b. Pertuzumab
  b. Pertuzumab
  c. Lapatinib
  c. Lapatinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  E. Platinum Based Therapies
  E. Platinum Based Therapies
  a. Cisplatin
  a. Cisplatin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Carboplatin
  b. Carboplatin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Oxaliplatin
  c. Oxaliplatin
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  F. Antimicrotubule Agents
  F. Antimicrotubule Agents
  a. Paclitaxel
  a. Paclitaxel
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Vinca Alkyloids
  b. Vinca Alkyloids
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  G. Antimetabolites
  G. Antimetabolites
  a. Fluorouracil
  a. Fluorouracil
  b. Capecitabine
  b. Capecitabine
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  H. Alkykating Agents
  H. Alkykating Agents
  a. cyclophosphamide
  a. cyclophosphamide
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  I. Anaplastic Lymphoma Kinase Inhibitors
  I. Anaplastic Lymphoma Kinase Inhibitors
  a. Crizotinib
  a. Crizotinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Ceritinib
  b. Ceritinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  J. PI3K-AKT-mTor Inhibitors
  J. PI3K-AKT-mTor Inhibitors
  a. Everolimus
  a. Everolimus
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Temsirolimus
  b. Temsirolimus
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  K. Bruton’s Tyrosine Kinase Inhibitors
  K. Bruton’s Tyrosine Kinase Inhibitors
  a. Ibrutinib
  a. Ibrutinib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  L. MEK Inhibitors
  L. MEK Inhibitors
  a. Trametnib
  a. Trametnib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  M. Immunomodulatory Drugs
  M. Immunomodulatory Drugs
  a. Lenalidomide
  a. Lenalidomide
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Thalidomide
  b. Thalidomide
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Pomalidomide
  c. Pomalidomide
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  N. Proteasome Inhibitors
  N. Proteasome Inhibitors
  a. Bortezomib
  a. Bortezomib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Carfilizomib
  b. Carfilizomib
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  O. Immune Checkpoint Inhibitors
  O. Immune Checkpoint Inhibitors
  a. Pembrolizumab
  a. Pembrolizumab
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  b. Nivolumab
  b. Nivolumab
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  c. Ipilimumab
  c. Ipilimumab
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  d. Additional Resources/Other
  d. Additional Resources/Other
  II. Radiation
  II. Radiation
  A. Coronary Artery Disease
  A. Coronary Artery Disease
  B. Valvular Disease
  B. Valvular Disease
  C. Constriction
  C. Constriction
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  D. Pericarditis
  D. Pericarditis
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  E. Device Checks
  E. Device Checks
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  F. Additional Resources/Other
  F. Additional Resources/Other
  III. Cardiomyopathy and Cancer Patients
  III. Cardiomyopathy and Cancer Patients
  A. Additional Resources/Other
  A. Additional Resources/Other
  IV. QT Monitoring
  IV. QT Monitoring
  A. Additional Resources/Other
  A. Additional Resources/Other
  V. Arrhythmias in Cancer Therapy
  V. Arrhythmias in Cancer Therapy
  A. Atrial Arrhythmias
  A. Atrial Arrhythmias
  • Cumulative Incidence, Risk Factors, and Management of Atrial Fibrillation in Patients Receiving Ibrutinib
    Wiczer, T. E., Levine, L. B., Brumbaugh, J., Coggins, J., Zhao, Q., Ruppert, A. S., Rogers, K., McCoy, A., Mousa, L., Guha, A., Heerema, N. A., Maddocks, K., Christian, B., Andritsos, L. A., Jaglowski, S., Devine, S., Baiocchi, R., Woyach, J., Jones, J., Grever, M., Blum, K. A., Byrd, J. C., & Awan, F. T. (2017). Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib. Blood Advances, 1(20), 1739-1748. Accessed September 09, 2018. Access here.
  B. Ventricular Arrhythmias
  B. Ventricular Arrhythmias
  C. Additional Resources/Other
  C. Additional Resources/Other
  VI. Pericardial Effusion
  VI. Pericardial Effusion
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  VII. Cancer and Percutaneous Coronary Intervention
  VII. Cancer and Percutaneous Coronary Intervention
  A. Cardiac Catheterization
  A. Cardiac Catheterization
  B. Post PCI anticoagulation
  B. Post PCI anticoagulation
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  C. Transaortic Valve Replacement In the Cancer Patient
  C. Transaortic Valve Replacement In the Cancer Patient
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  VIII. Anticoagulation in Cancer Patients
  VIII. Anticoagulation in Cancer Patients
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  IX. Peripheral Vascular Disease and the Cancer Patient
  IX. Peripheral Vascular Disease and the Cancer Patient
  A. Additional Resources/Other
  A. Additional Resources/Other
  X. Cardiac Masses
  X. Cardiac Masses
  A. Additional Resources/Other
  A. Additional Resources/Other
  XI. Cardiac Amyloid Related to Cancer
  XI. Cardiac Amyloid Related to Cancer
  A. Additional Resources/Other
  A. Additional Resources/Other
  XIII. Summary Articles
  XIII. Summary Articles
  A. Additional Resources/Other
  A. Additional Resources/Other
  XIV. Survivorship & Prevention
  XIV. Survivorship & Prevention
  C. Exercise/Obesity/Lifestyle
  C. Exercise/Obesity/Lifestyle
  D. Breast Survivorship
  D. Breast Survivorship
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  E. Lymphoma Survivorship
  E. Lymphoma Survivorship
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  F. Prostate Cancer Survivorship
  F. Prostate Cancer Survivorship
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  G. Sarcoma Survivorship
  G. Sarcoma Survivorship
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  H. Young Adulthood
  H. Young Adulthood
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  I. Pediatric Survivorship
  I. Pediatric Survivorship
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  J. Childhood Cancer Survivors and Heart Disease
  J. Childhood Cancer Survivors and Heart Disease
  XVI. Hormone Deprivation Therapies in Breast Cancer
  XVI. Hormone Deprivation Therapies in Breast Cancer
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  XVIII. Basic Science of Cardiotoxicity
  XVIII. Basic Science of Cardiotoxicity
  • Molecular Imaging of Apoptosis in Cancer Therapy-Related Cardiac Dysfunction Before LVEF Reduction
    Takehiro Nakahara, Artiom Petrov, Takashi Tanimoto, Farhan Chaudhry, Navneet Narula, Surya V. Seshan, Jeffrey A. Mattis, Koon Yan Pak, Gagan Sahni, Aarti Bhardwaj, Partho P. Sengupta, Amy Tiersten, H. William Strauss, Jagat Narula; JACC: Cardiovascular Imaging Aug 2018, 11 (8) 1203-1205; DOI: 10.1016/j.jcmg.2017.12.012
  • Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
    Mingchuan Li, Valentina Sala, Maria Chiara De Santis, James Cimino, Paola Cappello, Nicola Pianca, Anna Di Bona, Jean Piero Margaria, Miriam Martini, Edoardo Lazzarini, Flora Pirozzi, Luca Rossi, Irene Franco, Julia Bornbaum, Jacqueline Heger, Susanne Rohrbach, Alessia Perino, Carlo G. Tocchetti, Braulio H.F. Lima, Mauro M. Teixeira, Paolo E. Porporato, Rainer Schulz, Annalisa Angelini, Marco Sandri, Pietro Ameri, Sebastiano Sciarretta, Roberto César P. Lima-Júnior, Marco Mongillo, Tania Zaglia, Fulvio Morello, Francesco Novelli, Emilio Hirsch, Alessandra Ghigo; Circulation. 2018;138:696–711
  XIX. Biomarkers and Cardiotoxicity
  XIX. Biomarkers and Cardiotoxicity
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  XX. Carcinoid Heart Disease
  XX. Carcinoid Heart Disease
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  XXI. Cancer and Congenital Heart Disease
  XXI. Cancer and Congenital Heart Disease
  • Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series
    Alexander C. Egbe, Joseph T. Poterucha, Carole A. Warnes, Heidi M. Connolly, Shankar Baskar, Salil Ginde, Paul Clift, Brian Kogon, Wendy M. Book, Niki Walker, Lodewijk Wagenaar, Tabitha Moe, Erwin Oechslin, W. Aaron Kay, Mark Norris, Timothy Gordon-Walker Jonathan R. Dillman, Andrew Trout, Nadeem Anwar, Arvind Hoskoppal, Gruschen R. Veldtman; Circulation. 2018;138:746–748
  XXII. Imaging and Cardiotoxicity
  XXII. Imaging and Cardiotoxicity
  A. Echocardiography
  A. Echocardiography
  a. Strain
  a. Strain
  B. MRI
  B. MRI
  C. Nuclear Cardiology
  C. Nuclear Cardiology
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  Additional Resources/Other
  Additional Resources/Other
  XXIII. Preoperative Surgical Workup of the Cardio-oncology Patient
  XXIII. Preoperative Surgical Workup of the Cardio-oncology Patient
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  XXIV. Coronary Artery Bypass Grafting in the Cancer Patient
  XXIV. Coronary Artery Bypass Grafting in the Cancer Patient
Cardiology Magazine Image

Please help us populate this category!

Click the button below to submit content suggestions for this and any other category or sub-category.

Submit a Content Suggestion

  XXVI. Common Pathways of Cancer and Cardiac Disease
  XXVI. Common Pathways of Cancer and Cardiac Disease
  XXVII. Shared Prognostic Markers of Cancer and Cardiac Disease
  XXVII. Shared Prognostic Markers of Cancer and Cardiac Disease
  XXVIII. Guidelines and Consensus Statements
  XXVIII. Guidelines and Consensus Statements
  A. Additional Resources/Other
  A. Additional Resources/Other
  XXVIV. Trials
  XXVIV. Trials
  A. Additional Resources/Other
  A. Additional Resources/Other
  XXX. Cardiac Monitoring During and After Cancer Therapy
  XXX. Cardiac Monitoring During and After Cancer Therapy
  XXXI. Checkpoint Inhibitors
  XXXI. Checkpoint Inhibitors

Please help us make this a better resource for you!

Fill out the form below to submit content suggestions for any of the categories or to suggest a new category.